hepatocellular carcinomacirrhosisALDMASLDMet-ALDsteatotic liver diseaseG-CSFEMERALD
… a baseline MELD 3.0 score of 12–20. Exclusion criteria include hepatocellular carcinoma, portal vein thrombosis, significant hydrothorax, splenomegaly …
77articles mentioning diseases
588disease mentions
1distinct diseases extracted
0%of mentions human-reviewed
Active filtersEntity: MASLD ×
MASLD
This disease is selected. Its supporting articles are shown below.
Articles mentioning MASLD
77 articles · page 7 of 7hepatic encephalopathychronic liver diseaseliver cirrhosisMASLDRifaximinLactuloseLOLAAASLD
…, Dalal A. L-ornithine L-aspartate in acute treatment of severe hepatic encephalopathy: a double-blind randomized controlled trial. Hepatology. 2022 M…
MASLDmetabolic-dysfunction associated steatotic liver disease
…d a liver lesion seen on imaging. The most common diagnosis was MASLD, metabolic-dysfunction associated steatotic liver disease, (72.…
metabolic dysfunction-associated steatotic liver disease (MASLD)MASLDtertiary liver unitstructured group education programme
…nes recommend structured education programmes for patients with metabolic dysfunction-associated steatotic liver disease (MASLD); however, these are uncommon in practice. We developed and impl…
chronic liver diseaseMetabolic dysfunction-associated steatotic liver disease (MASLD)metabolic syndrome (MetS)steatosisMASLDmedicationpersonalised interventions
…ociated steatotic liver disease (MASLD) is the leading cause of chronic liver disease globally, with rising prevalence linked to metabolic syndrome (…